From PubMed Health:
Parkinson's disease is a disorder of the brain that leads to shaking (tremors) and difficulty with walking, movement, and coordination.
Parkinson's disease most often develops after age 50. It is one of the most common nervous system disorders of the elderly. Sometimes Parkinson's disease occurs in younger adults. It affects both men and women.
In some cases, Parkinson's disease runs in families. When a young person is affected, it is usually because of a form of the disease that runs in families.
Parkinson's disease occurs when the nerve cells in the brain that make dopamine are slowly destroyed. Dopamine is a brain chemical that nerve cells use to help control muscle movement. Without dopamine, the nerve cells in that part of the brain cannot properly send messages. This leads to the loss of muscle function. The damage gets worse with time. Exactly why these brain cells waste away is unknown.
The term "parkinsonism" refers to any condition that involves the types of movement changes seen in Parkinson's disease. Parkinsonism may be caused by other disorders (called secondary parkinsonism) or certain medications.
If one is diagnosed with Parkinson's disease, your doctor will treat the symptoms with various medications that will help increase the levels of dopamine in the brain. Sometimes a program of medication will have to be adjusted by your doctor because the helpful effects may wear off and symptoms can return. Many of these medications can cause severe side effects including hallucinations, nausea, vomiting, diarrhea and delirium.
In this case doctors are only treating the symptoms but not the root cause. Sadly, there is no known cure for Parkinson's disease. The goal of treatment is to control symptoms.
Recent studies are showing us evidence that Parkinson's disease is linked to low levels of glutathione in the body.
Here are some of the biomedical literatures and journals from PubMed about glutathione and Parkinson's disease:
Glutathione--a review on its role and significance in Parkinson's disease.
Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage?
Glutathione helps to preserve brain tissue by preventing damage from free radicals (acids) and destructive chemicals formed by the normal processes of metabolism, toxic elements in the environment, and as a normal response of the body to challenges by acidic agents or other stresses. With the understanding that glutathione is important for brain protection and that this protection may be lacking in the brains of Parkinson’s clients due to glutathione deficiency, it can be seen as very beneficial.
Glutathione if optimally given intravenously (IV) for Parkinson's disease is very beneficial but it is expensive, uncomfortable, and somewhat impractical requiring infusions 2 times per month (or more) using an Intravenous (IV) line. Glutathione precursors such as n acetyl cysteine (provided by Max GXL) are a better solution for chronic supplementation.
Max Gxl has been recommended by doctors for patients with Parkinson's disease.
This product doesn’t just get glutathione into the cells but it also helps the body recycle glutathione so it can be used over and over again. It can dramatically raise your glutathione levels, with increases up to 292%.
See the CLINICAL STUDIES of Max Gxl and how it can raise your glutathione levels.